• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/11/21 2:12:32 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care
    Get the next $CMD alert in real time by email
    SC 13G/A 1 cmd221.txt SCHEDULE 13G Amendment No. 1 Name of Issuer: Cantel Medical Corp. Title of Class of Securities: Common Stock CUSIP Number: 138098108 Item 1: Reporting Person: Wasatch Advisors, Inc. 87-0319391 Item 2: Check Box If Member of Group: Not Applicable Item 3: SEC Use Item 4: Place of Organization: Utah Items 5-8: Number of Shares Owned With: Item 5: Sole Voting Power: 83,005 Item 6: Shared Voting Power: 0 Item 7: Sole Dispositive Power: 83,005 Item 8: Shared Dispositive Power: 0 Item 9: Aggregate Amount Owned: 83,005 Item 10: Check Box If Aggregate Amount Excludes Certain Shares: N/A Item 11: Percent of Class Owned: 0.2% Item 12: Type of Reporting Person: IA Item 1(a): Name of Issuer: Cantel Medical Corp. Item l(b): Address of Issuer: Overlook At Great Notch, 150 Clove Road, Little Falls, NJ 07424 Item 2(a): Name of Person Filing: Wasatch Advisors, Inc. Item 2(b): Address: 505 Wakara Way, Salt Lake City, UT 84108 Item 2(c): Citizenship: Not Applicable Item 2(d): Title of Class of Securities: Common Stock Item 2(e): CUSIP Number: 138098108 Item 3(e): Investment Adviser registered under section 203 of the Investment Advisers Act of 1940 Item 4(a): Amount Owned: 83,005 Item 4(b): Percent of Class Owned: 0.2% Item 4(c)(i): Sole Voting Power: 83,005 Item 4(c)(ii): Shared Voting Power: 0 Item 4(c)(iii): Sole Dispositive Power: 83,005 Item 4(c)(iv): Shared Dispositive Power: 0 Item 5: Check Box If Ownership Is 5% or Less of Class: [X] Item 6. Ownership of More Than 5% on Behalf of Another Person: N/A Item 7: Identification of Subsidiary: Not Applicable Item 8: Identification of Members of Group: Not Applicable Item 9: Notice of Dissolution of Group: Not Applicable Item 10: Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct as of December 31, 2020. Date: 02/11/21 Signature: /s/JB Taylor Name/Title: JB Taylor/CEO
    Get the next $CMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CMD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Cantel Medical Corp.

    4 - CANTEL MEDICAL CORP (0000019446) (Issuer)

    6/2/21 5:27:45 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Cantel Medical Corp.

    4 - CANTEL MEDICAL CORP (0000019446) (Issuer)

    6/2/21 5:28:15 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Cantel Medical Corp.

    4 - CANTEL MEDICAL CORP (0000019446) (Issuer)

    6/2/21 5:27:18 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    $CMD
    SEC Filings

    View All

    SEC Form SC TO-I/A filed by Cantel Medical Corp. (Amendment)

    SC TO-I/A - CANTEL MEDICAL LLC (0000019446) (Subject)

    7/2/21 4:06:30 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    SEC Form SC TO-I/A filed by Cantel Medical Corp. (Amendment)

    SC TO-I/A - CANTEL MEDICAL LLC (0000019446) (Subject)

    6/29/21 4:16:59 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    SEC Form 15-12B filed by Cantel Medical Corp.

    15-12B - CANTEL MEDICAL LLC (0000019446) (Filer)

    6/14/21 4:06:30 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    $CMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sanitizing Agents Market Poised for over 7.8% Growth by 2029, Growing by Increasing Investment in The Development of Eco-Friendly Acid-Based Chemicals: States by Exactitude Consultancy

    The Sanitizing Agents Market size is expected to reach 32.34 USD billion by 2029; Sanitizing Agents are a necessary sanitary product for maintaining hygiene and cleanliness in homes and environments PUNE, India, Sept. 21, 2022 /PRNewswire/ -- Sanitation has become an important aspect of the major industrial processes and commercial sectors. Sanitizing agents are being used more frequently to maintain a level of sanitation. The growing awareness of the importance of food product quality is a major reason why demand for sanitizing agents is expected to rise due to their efficiency and cost-effectiveness. Access PDF Sample Report (Including Graphs, Charts & Figures) @ https://exactitudeconsulta

    9/21/22 11:30:00 AM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    Crocs Set to Join S&P MidCap 400 and Organogenesis to Join S&P SmallCap 600

    NEW YORK, May 26, 2021 /PRNewswire/ -- S&P SmallCap 600 constituent Crocs Inc. (NASD:CROX) will replace Cantel Medical Corp. (NYSE:CMD) in the S&P MidCap 400, and Organogenesis Holdings Inc. (NASD: ORGO) will replace Crocs in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, June 2, 2021. STERIS plc (NYSE:STE) is acquiring Cantel Medical in a deal expected to be completed soon pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector June 2, 2021 S&P MidCap 400 Addition Crocs CROX Consumer Discretionary S&P M

    5/26/21 5:50:00 PM ET
    $STE
    $CMD
    $SPGI
    Industrial Specialties
    Health Care
    Medical/Dental Instruments
    Finance: Consumer Services

    Mar Cor Launches Its Newest and Most Advanced Portable Reverse Osmosis Water System

    The EON™ Portable Dialysis Water System produces high-quality medical water for acute and home hemodialysis use Mar Cor Purification, Inc., a Cantel Medical Corp. (NYSE:CMD) business, announces the launch of the EON™ Portable Dialysis Water System. The portable water purification device uses reverse osmosis (RO) to remove organic and inorganic substances and microbial contaminants from water that feeds into hemodialysis machines to treat hemodialysis patients or related therapies. The water system quickly delivers and efficiently produces medical-grade water for single-patient hemodialysis treatments in hospitals, clinics, skilled nursing centers, and home environments. This press release

    5/6/21 11:04:00 AM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    $CMD
    Leadership Updates

    Live Leadership Updates

    View All

    Cantel Announces Senior Leadership Promotions in Dental

    LITTLE FALLS, N.J., Dec. 3, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) announced today the appointment of Andy Xilas to President, Cantel Dental effective January 1, 2021. He will be taking over for Ken Serota, who will be stepping down as President effective December 31, 2020. In addition, Jennifer Naylor has been appointed to the newly created role of Senior Vice President, Infection Prevention and Control Strategy and Education for Cantel. Mr. Xilas and Ms. Naylor both joined Cantel in 2019, as part of Cantel's acquisition of Hu-Friedy and will sit on the Company's Executive Leadership Team. Mr. Xilas has held various positions at Hu-Friedy with increasing responsibility over

    12/3/20 9:00:00 AM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    $CMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Cantel Medical Corp.

    SC 13G - CANTEL MEDICAL LLC (0000019446) (Subject)

    6/10/21 4:11:25 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Cantel Medical Corp. (Amendment)

    SC 13G/A - CANTEL MEDICAL CORP (0000019446) (Subject)

    5/10/21 12:31:25 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed

    SC 13G/A - CANTEL MEDICAL CORP (0000019446) (Subject)

    3/10/21 4:38:59 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care